UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial

Diabetes care, 2018-10, Vol.41 (10), p.2147-2154

2018

Volltextzugriff (PDF)

Improved detectability of acute and subacute brainstem infarctions by combining standard axial and thin-sliced sagittal DWI

PloS one, 2018-07, Vol.13 (7), p.e0200092-e0200092

2018

Volltextzugriff (PDF)

Bessere Aussichten für Patienten mit Typ-2-Diabetes

MMW Fortschritte der Medizin, 2016, Vol.158 (1), p.45-49

Ritzel, Robert A.

2016

Volltextzugriff (PDF)

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Diabetes (New York, N.Y.), 2003-01, Vol.52 (1), p.102-110

2003

Volltextzugriff (PDF)

GLP-1-Analoga: Was ist in der Praxis zu beachten?

MMW Fortschritte der Medizin, 2020-04, Vol.162 (7), p.51-54

Ritzel, Robert

2020

Volltextzugriff (PDF)

GLP-1-Analoga: Was ist in der Praxis zu beachten?: Seminar/Diabetes

MMW Fortschritte der Medizin, 2020-04, Vol.162 (7), p.51-54

Ritzel, Robert

2020

Volltextzugriff (PDF)

Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets

Diabetes (New York, N.Y.), 2007-01, Vol.56 (1), p.65-71

2007

Volltextzugriff (PDF)

Therapeutic approaches based on beta-cell mass preservation and/or regeneration

Frontiers in bioscience (Landmark. Print), 2009-01, Vol.14 (5), p.1835-1850

Ritzel, Robert A

2009

Volltextzugriff (PDF)

Relationship between β-cell mass and fasting blood glucose concentration in humans

Diabetes care, 2006-03, Vol.29 (3), p.717-718

2006

Volltextzugriff (PDF)

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

Diabetes, obesity & metabolism, 2018-12, Vol.20 (12), p.2860-2868

2018

Volltextzugriff (PDF)

Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis

Diabetes (New York, N.Y.), 2003-07, Vol.52 (7), p.1701-1708

2003

Volltextzugriff (PDF)

Pancreatic β-Cells Secrete Insulin in Fast- and Slow-Release Forms

Diabetes (New York, N.Y.), 2006-03, Vol.55 (3), p.600-607

2006

Volltextzugriff (PDF)

Impaired islet turnover in human donor pancreata with aging

European journal of endocrinology, 2009-02, Vol.160 (2), p.185

2009

Volltextzugriff (PDF)

Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers

The journal of clinical endocrinology and metabolism, 2002-03, Vol.87 (3), p.1239-1246

2002

Volltextzugriff (PDF)

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

American journal of physiology: endocrinology and metabolism, 1997-11, Vol.273 (5), p.E981-E988

1997

Volltextzugriff (PDF)

Annexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity

Biochemistry (Easton), 2009-11, Vol.48 (44), p.10568-10576

2009

Volltextzugriff (PDF)

Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine

Diabetes care, 2008-06, Vol.31 (6), p.1105-1111

2008

Volltextzugriff (PDF)

Important endpoint trials in diabetes mellitus - impact on clinical care

MMW Fortschritte der Medizin, 2016-01, Vol.158 (1), p.45-49

Ritzel, Robert A

2016

Volltextzugriff (PDF)

Glycemic Control and Hypoglycemia Benefits with Insulin Glargine 300 U/mL (Gla-300) Extend to People with Type 2 Diabetes and Mild-to-Moderate Renal Impairment

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S47-S47

2016

Volltextzugriff (PDF)

Comparison of Pancreas-Transplanted Type 1 Diabetic Patients with Portal-Venous Versus Systemic-Venous Graft Drainage: Impact on Glucose Regulatory Hormones and the Growth Hormone/Insulin–Like Growth Factor-I Axis

The journal of clinical endocrinology and metabolism, 2008-05, Vol.93 (5), p.1758-1766

2008

Volltextzugriff (PDF)

Beta-cell selective KATP-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity

Regulatory peptides, 2010-12, Vol.165 (2-3), p.158-162

2010

Volltextzugriff (PDF)

Glucose Stimulates Pulsatile Insulin Secretion from Human Pancreatic Islets by Increasing Secretory Burst Mass: Dose-Response Relationships

The journal of clinical endocrinology and metabolism, 2003-02, Vol.88 (2), p.742-747

2003

Volltextzugriff (PDF)

Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (2), p.648-653

2013

Volltextzugriff (PDF)

Advancing Type 2 Diabetes Therapy with iGlarLixi in Older People: Pooled Analysis of Four Randomized Controlled Trials

Metabolism, clinical and experimental, 2023-05, Vol.142, p.155429, Article 155429

2023

Volltextzugriff (PDF)

775-P: Predictors of Glycemic Control in Older People with Type 2 Diabetes Treated with iGlarLixi—A Pooled Analysis

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(69)
Deutsch
(11)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(27)
Diabetes
(24)
Endocrinology & Metabolism
(23)
Insulin
(17)
Biological And Medical Sciences
(16)
Male
(14)
Medical Sciences
(12)
Diabetes Mellitus
(11)
Endocrinopathies
(11)
Aged
(10)
Female
(10)
Insulin - Metabolism
(10)
Middle Aged
(10)
Type 2 Diabetes
(10)
Diabetes. Impaired Glucose Tolerance
(9)
Endocrine Pancreas. Apud Cells
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial

Improved detectability of acute and subacute brainstem infarctions by combining standard axial and thin-sliced sagittal DWI

Bessere Aussichten für Patienten mit Typ-2-Diabetes

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

GLP-1-Analoga: Was ist in der Praxis zu beachten?

GLP-1-Analoga: Was ist in der Praxis zu beachten?: Seminar/Diabetes

Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets

Therapeutic approaches based on beta-cell mass preservation and/or regeneration

Relationship between β-cell mass and fasting blood glucose concentration in humans

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis

Pancreatic β-Cells Secrete Insulin in Fast- and Slow-Release Forms

Impaired islet turnover in human donor pancreata with aging

Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

Annexin A5 Directly Interacts with Amyloidogenic Proteins and Reduces Their Toxicity

Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine

Important endpoint trials in diabetes mellitus - impact on clinical care

Glycemic Control and Hypoglycemia Benefits with Insulin Glargine 300 U/mL (Gla-300) Extend to People with Type 2 Diabetes and Mild-to-Moderate Renal Impairment

Comparison of Pancreas-Transplanted Type 1 Diabetic Patients with Portal-Venous Versus Systemic-Venous Graft Drainage: Impact on Glucose Regulatory Hormones and the Growth Hormone/Insulin–Like Growth Factor-I Axis

Beta-cell selective KATP-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity

Glucose Stimulates Pulsatile Insulin Secretion from Human Pancreatic Islets by Increasing Secretory Burst Mass: Dose-Response Relationships

Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

Advancing Type 2 Diabetes Therapy with iGlarLixi in Older People: Pooled Analysis of Four Randomized Controlled Trials

775-P: Predictors of Glycemic Control in Older People with Type 2 Diabetes Treated with iGlarLixi—A Pooled Analysis

Suchergebnisse filtern